Lyra Therapeutics (LYRA) Asset Utilization Ratio (2021 - 2025)
Lyra Therapeutics (LYRA) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.02 as the latest value for Q3 2025.
- On a quarterly basis, Asset Utilization Ratio fell 214.31% to 0.02 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.02, a 214.31% decrease, with the full-year FY2023 number at 0.01, down 25.4% from a year prior.
- Asset Utilization Ratio was 0.02 for Q3 2025 at Lyra Therapeutics, down from 0.01 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.02 in Q3 2024 to a low of 0.02 in Q3 2025.
- A 5-year average of 0.01 and a median of 0.01 in 2023 define the central range for Asset Utilization Ratio.
- Peak YoY movement for Asset Utilization Ratio: soared 155.62% in 2022, then tumbled 214.31% in 2025.
- Lyra Therapeutics' Asset Utilization Ratio stood at 0.0 in 2021, then skyrocketed by 155.62% to 0.01 in 2022, then dropped by 0.35% to 0.01 in 2023, then soared by 43.35% to 0.02 in 2024, then plummeted by 214.31% to 0.02 in 2025.
- Per Business Quant, the three most recent readings for LYRA's Asset Utilization Ratio are 0.02 (Q3 2025), 0.01 (Q2 2025), and 0.01 (Q1 2025).